PepGen Inc (PEPG)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James G. McArthur
Employees:
30
1 MARINA PARK DRIVE, SUITE 900, BOSTON, MA 02210
703-456-8000

PepGen Inc. focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy.

Data derived from most recent annual or quarterly report
Market Cap 418.285 Million Shares Outstanding23.632 Million Avg 30-day Volume 29.768 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.79
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value1.1089 Operating Margin0.0 Enterprise Value18.164 Million
Current Ratio13.161 EPS Growth0 Quick Ratio12.866
1 Yr BETA 1.2607 52-week High/Low 17.99 / 4.32 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score8.7676 Free Cash Flow to Firm 0
Earnings Report2023-03-30
View SEC Filings from PEPG instead.

View recent insider trading info

PepGen Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding PEPG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PEPG

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-02 by MELLION MICHELLE L
  • 4: filed on 2023-03-02 by Svenstrup Niels
  • 4: filed on 2023-03-02 by MCARTHUR JAMES G
  • 4: filed on 2023-03-02 by DONNELLY NOEL
  • 4: filed on 2023-02-08 by GOYAL JAYA
  • 4: filed on 2023-01-19 by KEATING LAURIE
  • 4: filed on 2022-12-19 by Svenstrup Niels
  • 4: filed on 2022-10-03 by DABLE HABIB J
  • 3: filed on 2022-09-22 by DABLE HABIB J
  • 4: filed on 2022-08-31 by MELLION MICHELLE L

    • Events (8k)

  • 8-K: filed on 2022-12-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-28:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    6 Thousand total shares from 3 transactions

    Exercise Derivative Conversion (M)

    6 Thousand total shares from 3 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MCARTHUR JAMES G PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2023-03-01 3

    SVENSTRUP NIELS SVP, CHEM. MFG & CONTROLS

    • Officer
    		 0 2023-03-01 4

    DONNELLY NOEL CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-03-01 3

    GOYAL JAYA EVP, RES. & PRECLIN. DEV.

    • Officer
    		 0 2023-03-01 4

    MELLION MICHELLE L SVP, CLINICAL DEVELOPMENT

    • Officer
    		 0 2023-03-01 4

    DABLE HABIB J

    • Director
    		 22,686 2022-10-03 2

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MGMT V, L.P.

    DEERFIELD PRIVATE DESIGN FUND V, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 1,222,106 2022-05-10 2

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND II, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 8,131,952 2022-05-10 4

    OXFORD SCIENCE ENTERPRISES PLC

    • 10% Owner
    		 3,875,418 2022-05-10 2

    HENSON HEIDI

    • Director
    		 11,667 2022-05-06 2

    KEATING LAURIE

    • Director
    		 4,166 2022-05-06 3

    RESNICK JOSHUA

    • Director
    		 11,667 2022-05-06 2

    BRACEGIRDLE SONIA SEE REMARKS

    • Officer
    		 79,547 2022-05-06 2

    ASHTON CHRISTOPHER

    • Director
    		 11,667 2022-05-06 2

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DONNELLY NOEL - Officer CHIEF FINANCIAL OFFICER

    		2023-03-02 16:33:54 -0500 2023-03-01 A 144,000 a 144,000 direct

    MCARTHUR JAMES G - Director - Officer PRESIDENT AND CEO

    		2023-03-02 16:37:56 -0500 2023-03-01 A 275,000 a 275,000 direct

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-03-02 16:46:06 -0500 2023-03-01 A 75,000 a 75,000 direct

    SVENSTRUP NIELS - Officer SVP, CHEM. MFG & CONTROLS

    		2023-03-02 16:42:21 -0500 2023-03-01 A 75,000 a 75,000 direct

    MELLION MICHELLE L - Officer SVP, CLINICAL DEVELOPMENT

    		2023-03-02 16:53:24 -0500 2023-03-01 A 20,000 a 95,000 direct

    MELLION MICHELLE L - Officer SVP, CLINICAL DEVELOPMENT

    		2023-03-02 16:53:24 -0500 2023-03-01 A 75,000 a 75,000 direct

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-08 M 644 $10.88 a 644 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-08 S 644 $17.00 d 0 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-08 M 644 d 144,196 direct yes

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-07 M 3,679 $10.88 a 3,679 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-07 S 3,679 $17.18 d 0 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-07 M 3,679 d 144,840 direct yes

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-06 M 1,677 $10.88 a 1,677 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-06 S 1,677 $17.04 d 0 direct yes 4.8466 1.5951 8.589 3 0.0 1

    GOYAL JAYA - Officer EVP, RES. & PRECLIN. DEV.

    		2023-02-08 17:42:32 -0500 2023-02-06 M 1,677 d 148,519 direct yes

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PEPGEN INC PEPG 2023-03-20 12:45:03 UTC -7.0436 11.6136 15000
    PEPGEN INC PEPG 2023-03-17 22:15:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 21:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 21:15:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 20:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 20:15:06 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 19:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 19:15:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 18:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 18:15:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 17:45:04 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 17:15:05 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 16:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 16:15:04 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 15:45:04 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 15:15:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 14:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 14:15:04 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 13:45:03 UTC -7.0436 11.6136 65000
    PEPGEN INC PEPG 2023-03-17 13:15:03 UTC -7.0436 11.6136 65000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments